Back to search

Netherlands· NL-583ae435e250

Zofil 15 mg filmomhulde tabletten

A zofenopril product containing zofenopril calcium, registered in Netherlands by Menarini International Operations Luxembourg S.A.. The same ATC class is registered in 10 of our 19 countries.

ATC C09AA15

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedZofil 15 mg filmomhulde tablettenATCC09AA15REGISTER NO.NL-583ae435e250PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Zofenopril is registered in 10 of 19 countries.

Countries holding a registration under ATC C09AA15 (zofenopril), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose

Zofenopril · ATC C09AA15

10 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Netherlands
  • Polandprice
  • Spainprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of zofenopril costs, country by country.

Normalised to the WHO defined daily dose (30 mg), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Zofenopril · price per daily dose (30 mg)

USD · FX 28 Sept 2026

  • FR France$0.43
  • IT Italy$0.36
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ZOFENOPRIL CALCIUM
Manufacturer
Menarini International Operations Luxembourg S.A.
Country
Netherlands (NL)
ATC code
C09AA15
ATC class
Zofenopril
Defined daily dose
30 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    23721

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

52 interactions on record for zofenopril.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Zofenopril · interactions on record

52 records

52 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Zofenopril in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All zofenopril products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

  • Belgium · Zopranol
  • Bulgaria · Зофен
  • Germany · Zofenil
  • Estonia · Zofistar
  • France · Zofenil, Zofenopril Viatris
  • Greece · Zofepril
  • Croatia · Zofecard
  • Hungary · Zofipress
  • Ireland · Zofenil
  • Italy · Bifril, Zantipres
  • Lithuania · Zofenopril Ingen Pharma, Zofistar
  • Luxembourg · Zopranol
  • Latvia · Zofistar
  • Poland · Zofenil
  • Portugal · Zofenil, Zofenopril Mylan
  • Romania · Zomen
  • Slovenia · Tenzopril
  • Slovakia · Zofaril

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0825f3bd-3ab7-47bc-9002-808de88bbd83
GET /v1/drugs/0825f3bd-3ab7-47bc-9002-808de88bbd83?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h23721_smpc.pdf",
  "strength": null,
  "atc_label": "Zofenopril",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg23721",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "HYPROMELLOSE (E 464)",
    "LACTOSE 1-WATER",
    "MACROGOL 400",
    "MACROGOL 6000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "SILICIUMDIOXIDE (E 551)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "ZOFENOPRIL CALCIUM"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h23721.pdf",
  "authorised_at": "1999/04/22",
  "procedure_number": "NL/H/4675/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "23721",
  "additional_monitoring": "N"
}

See everything about zofenopril.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.